A new and simple method for the determination of hydroxylamine in environmental water, such as fresh rivers and lakes using hypochlorite, followed by its gas choromatographic detection, has been developed. A glass vial filled with sample water was sealed by a butyl-rubber stopper and aluminum cap without head-space, and then sodium hypochlorite solution was injected into the vial through a syringe to convert hydroxylamine to nitrous oxide. The head-space in the glass vial was prepared with 99.9% grade N2 using a gas-tight syringe. After the glass vial was shaken for a few minutes, nitrous oxide in the gas-phase was measured by a gas chromatograph with an electron-capture detector. The dissolved nitrous oxide in the liquid-phase was calculated according to the solubility formula. The proposed method was applied to the analysis of fresh-water samples taken from Iu river and Hii river, flowing into brackish Lakes Nakaumi and Shinji, respectively.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2116/analsci.20.139 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Numerical modeling of conventional spin-stop agitation of liquid drug products for automated visual inspection.
Int J Pharm
January 2025
Amgen Inc., Process Development, Manufacturing Technology Advancement (MTA) Group, Thousand Oaks, CA 91320, USA. Electronic address:
Article Synopsis
- The automated visual inspection (AVI) of liquid-filled vials and syringes in pharmaceutical production uses a spin-stop motion to detach particles for better detection.
- A validated numerical model for a specific glass vial was created to study how different agitation motions and liquid properties affect particle mobilization.
- Findings indicate that higher angular acceleration during agitation improves the wall shear stress distribution, enhancing particle detection, and the developed model can be adapted for various container types and liquids to optimize AVI processes.
Assessing Drug Product Shelf Life Using the Accelerated Stability Assessment Program: A Case Study of a GLPG4399 Capsule Formulation.
Pharmaceutics
October 2024
Analytical, AnaBioTec NV, Noorwegenstraat 4, 9940 Evergem, Belgium.
To evaluate and project the shelf life of GLPG4399, an early-phase clinical drug formulation by applying the Accelerated Stability Assessment Program (ASAP) approach. Forced degradation conditions were implemented to identify the stability-limiting degradation product. The drug and its degradation products were separated using a validated liquid chromatography method.
View Article and Find Full Text PDFA Container Closure Integrity Test Method for Vials Stored at Cryogenic Conditions Using Headspace Oxygen Analysis.
PDA J Pharm Sci Technol
December 2024
Lighthouse Instruments, LLC., Charlottesville, VA 22902.
An increasing number of pharmaceutical products require deep cold storage at cryogenic conditions, approximately -150°C to -190°C, to maintain stability and/or activity. Previous work has revealed that, at these extreme conditions, a typical pharmaceutical package configuration (vial, stopper, crimp cap) may lose container closure integrity (CCI) due to both the glass transition temperature (-55°C to -70°C) of the rubber stopper used to seal the vial and the different thermal expansion coefficients of the primary packaging components. Importantly, this type of temporary breach in CCI frequently reseals itself when the vial is brought back to ambient temperature.
View Article and Find Full Text PDFDevelopment of compact electrolytic enrichment system for environmental tritium analysis.
Radiat Prot Dosimetry
November 2024
Department of Nuclear and Radiochemical Science, Kyushu Environmental Evaluation Association, 1-10-1 Matsukadai, Higashiku Fukuoka 813-0004, Japan.
The new electrolytic enrichment system with compact glass cell was designed. Three (Ni-Fe-Ni) electrodes are used, and electrolysis is carried out at a rate of 2.45 g per h with constant current density of 120 mA per cm2.
View Article and Find Full Text PDFAnalytical microscopy techniques using coaxial and oblique illuminations to detect thin glass particulates generated from glass vials for parenteral drug products.
Appl Microsc
October 2024
Analytical Development and Operations, Gilead Sciences Inc, Foster City, CA, 94404, USA.
Glass vials are the most widely used primary containers for the packaging of parenteral products due to their optical clarity, general inertness, and hermetic properties, but under certain circumstances, they can pose safety concerns. Most of these issues are related to the potential formation of glass particulates through delamination or precipitation, resulting from the chemical interaction between the drug product and the inner surface of the glass vial. Hence, it is imperative for pharmaceutical companies to conduct product-vial compatibility studies to determine the appropriate packaging/container closure system.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!